Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral melatonin for treatment of oral mucositis and pain in upper gastrointestinal tract tumor patients
IRCT20220426054666N1Phase 2Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in stomatitis, mouth pain and Upper gastrointestinal tract cancer, sponsored by Alborz University of Medical Sciences. Primary endpoints: Improvement in oral mucositis and Reduction in oral pain. Started Aug 2022; status: completed.
02
Drugs
melatonin
03
Conditions
stomatitismouth painUpper gastrointestinal tract cancer
Beyond the preview
Go deeper on IRCT20220426054666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220426054666N1.